title: Clinicopathologic reports, case reports, and small case series: 0.01% becaplermin gel for the treatment of a chronic orbital ulcer after exenteration.
authors.affiliation: Department of Ophthalmology, Krieger Eye Institute, Sinai Hospital of Baltimore, 2411 W Belvedere Ave, Baltimore, MD 21215, USA.
authors.forename: I
authors.initials: I
authors.lastname: Yassur
authors.forename: M J
authors.initials: MJ
authors.lastname: Hirschbein
authors.forename: J W
authors.initials: JW
authors.lastname: Karesh
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D000077214:Becaplermin; D002908:Chronic Disease; D004847:Epithelial Cells / Q000187:drug effects / Q000473:pathology; D005782:Gels; D006801:Humans; D008297:Male; D008545:Melanoma / Q000601:surgery; D008875:Middle Aged; D017233:Orbit Evisceration / Q000009:adverse effects*; D009916:Orbital Diseases / Q000188:drug therapy* / Q000209:etiology; D009918:Orbital Neoplasms / Q000601:surgery; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use*; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins / Q000627:therapeutic use; D014456:Ulcer / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000925:Anticoagulants; D005782:Gels; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin